Severity
Low
LowClass IIITerminated
FDA Drug recall · Reported January 23, 2013
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
Teva Pharmaceuticals USA, Inc. recalled CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTI… - a low-severity action.
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTI… was recalled by Teva Pharmaceuticals USA, Inc. in January 23, 2013. Reason: Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life. Check the official notice for the remedy. Verify recall #D-128-2013 with the FDA Drug before acting.
The recall
Teva Pharmaceuticals USA, Inc. issued this low-severity FDA Drug recall-Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life.
- Low
- severity level
- Class III
- classification
- January 23, 2013
- reported
Sourced from official FDA Drug enforcement records. Verify recall #D-128-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This FDA Drug action (record #D-128-2013) was formally reported on January 23, 2013, with the manufacturer initiating the action on April 24, 2012. It is classified under Low severity (Class III), with a current status of Terminated. Teva Pharmaceuticals USA, Inc. is listed as the recalling firm, operating out of Sellersville, PA. Federal records list the affected scope as 13,232 bottles.
The documented reason for this recall is: Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Household Products recalls over time
Where this recall sits in its category - 3,056 household products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Affected scope
13,232 bottles
Related Recalls
6
0 from same agency
Product description
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
Reason for recall
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-128-2013 |
| Date reported | January 23, 2013 |
| Date initiated | April 24, 2012 |
| Recalling firm | Teva Pharmaceuticals USA, Inc. |
| Firm location | Sellersville, PA |
| Affected scope | 13,232 bottles |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
- Check the recall number (D-128-2013) and product description against the item you own. Search the archive
- Confirm the current status with FDA Drug before acting, recall details can be updated.
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88. Recalled by Teva Pharmaceuticals USA, Inc.. Units affected: 13,232 bottles.
Why was this product recalled? ▼
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on January 23, 2013. Severity: Low. Recall number: D-128-2013.
Where was the recalled product distributed? ▼
Distribution: Nationwide.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (D-128-2013) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device? ▼
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.
Nearby Recalls in This Category
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
CPSC Moderate
Cooper Lighting Recalls Metalux Optimized High Bay LED Light Fixtures Due to Fire Hazard
Cooper Lighting, LLC, of Peachtree City, Georgia · 2026-07-02
CPSC Moderate
Winco Fireworks International Recalls Roman Candles 8 Shot Fireworks Due to Risk of Serious Injury from Explosion and B…
· 2026-07-02
CPSC Moderate
Winco Fireworks International Recalls Unity 7 Shot 200 Gram Aerial Cake Fireworks Due to Risk of Serious Injury from Ex…
· 2026-07-02
CPSC Moderate
Kith Retail Recalls Children's Loungewear Sets Due to Risk of Serious Injury from Burn Hazard; Violate Mandatory Standa…
· 2026-06-25
CPSC Moderate
Southern Telecom Expands Recall of Lomi Waxing Kits Due to Risk of Serious Injury or Death from Fire and Burn Hazards; …
· 2026-06-25
Compare this recall with Cooper Lighting Recalls Metalux Optimized High Bay LED Ligh… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported January 23, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.